Tuberculosis Epidemiologic Studies Consortium III

The purpose of this RFP is to establish one or more contracts to conduct a multicenter epidemiologic research study using the principles of implementation science to identify the characteristics of LTBI targeted testing and treatment programs that are associated with the greatest effectiveness (maximizing number of LTBI cases detected and completely treated according to CDC guidelines) and efficiency (minimizing the cost per LTBI case detected and completely treated). To meet the requirements in FAR 5.302, the following information is provided (in addition to what it is already in this SAM.gov posting): Performance Start Date: 9/29/2021 Performance Period: Base 18-month period, and three (3) one-year option periods Contact Point or Contracting Officer: Martin F. Nemec Contracting Office Address: CDC OAS, 2900 Woodcock Blvd, Atlanta, GA 30341 Proposed Solicitation Number: 75D301-21-R-71814 Closing Response Date: July 9, 2021 Place of Contract Performance: Contractor Location Set-aside Status: None.